{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:24:25Z","timestamp":1792157065951,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,16]],"date-time":"2018-06-16T00:00:00Z","timestamp":1529107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone Reports"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.bonr.2018.06.005","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T18:23:48Z","timestamp":1529605428000},"page":"42-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Juvenile onset IIH and CYP24A1 mutations"],"prefix":"10.1016","volume":"9","author":[{"given":"Karl P.","family":"Schlingmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walburga","family":"Cassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Konrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bonr.2018.06.005_bb0005","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.jpeds.2013.04.056","article-title":"Lightwood syndrome revisited with a novel mutation in CYP24 and vitamin D supplement recommendations","volume":"163","author":"Castanet","year":"2013","journal-title":"J. Pediatr."},{"issue":"3","key":"10.1016\/j.bonr.2018.06.005_bb0010","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/ndt\/gft460","article-title":"Chronic hypercalcaemia from inactivating mutations of vitamin D 24-hydroxylase (CYP24A1): implications for mineral metabolism changes in chronic renal failure","volume":"29","author":"Colussi","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bonr.2018.06.005_bb0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bone.2015.06.018","article-title":"Calcium and bone homeostasis in heterozygous carriers of CYP24A1 mutations: a cross-sectional study","volume":"81","author":"Cools","year":"2015","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.bonr.2018.06.005_bb0020","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1681\/ASN.2013101085","article-title":"Mutations in SLC34A3\/NPT2c are associated with kidney stones and nephrocalcinosis","volume":"25","author":"Dasgupta","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.bonr.2018.06.005_bb0025","doi-asserted-by":"crossref","first-page":"E268","DOI":"10.1210\/jc.2011-1972","article-title":"Genetic defect in CYP24A1, the vitamin D 24-hydroxylase gene, in a patient with severe infantile hypercalcemia","volume":"97","author":"Dauber","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.bonr.2018.06.005_bb0030","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/archdischild-2011-301284","article-title":"Investigation and management of hypercalcaemia in children","volume":"97","author":"Davies","year":"2012","journal-title":"Arch. Dis. Child."},{"issue":"2","key":"10.1016\/j.bonr.2018.06.005_bb0035","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.juro.2013.02.3188","article-title":"Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis","volume":"190","author":"Dinour","year":"2013","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.bonr.2018.06.005_bb0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00467-014-2889-1","article-title":"Maternal and infantile hypercalcemia caused by vitamin-D-hydroxylase mutations and vitamin D intake","volume":"30","author":"Dinour","year":"2015","journal-title":"Pediatr. Nephrol."},{"issue":"12","key":"10.1016\/j.bonr.2018.06.005_bb0045","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1007\/s00467-016-3443-0","article-title":"Loss of function of NaPiIIa causes nephrocalcinosis and possibly kidney insufficiency","volume":"31","author":"Dinour","year":"2016","journal-title":"Pediatr. Nephrol."},{"issue":"38","key":"10.1016\/j.bonr.2018.06.005_bb0050","first-page":"908","article-title":"Chronic disorders of calcium and phosphate metabolism in children","volume":"81","author":"Fanconi","year":"1951","journal-title":"Schweiz. Med. Wochenschr."},{"issue":"1","key":"10.1016\/j.bonr.2018.06.005_bb0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00431-012-1818-1","article-title":"Severe hypercalcemic crisis in an infant with idiopathic infantile hypercalcemia caused by mutation in CYP24A1 gene","volume":"172","author":"Fencl","year":"2013","journal-title":"Eur. J. Pediatr."},{"issue":"1","key":"10.1016\/j.bonr.2018.06.005_bb0060","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1053\/j.ajkd.2014.06.037","article-title":"Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations","volume":"65","author":"Figueres","year":"2015","journal-title":"Am. J. Kidney Dis."},{"issue":"5","key":"10.1016\/j.bonr.2018.06.005_bb0065","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jc.2016-4048","article-title":"CYP3A4 induction by rifampin: an alternative pathway for vitamin D inactivation in patients with CYP24A1 mutations","volume":"102","author":"Hawkes","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.bonr.2018.06.005_bb0070","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1007\/s00467-006-0217-0","article-title":"Long-term follow-up of patients with idiopathic infantile hypercalcaemia","volume":"21","author":"Huang","year":"2006","journal-title":"Pediatr. Nephrol."},{"issue":"3","key":"10.1016\/j.bonr.2018.06.005_bb0075","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1210\/jc.2013-3802","article-title":"A lifetime of hypercalcemia and hypercalciuria, finally explained","volume":"99","author":"Jacobs","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.bonr.2018.06.005_bb0080","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1159\/000368520","article-title":"Discordant clinical course of vitamin-D-hydroxylase (CYP24A1) associated hypercalcemia in two adult brothers with nephrocalcinosis","volume":"40","author":"Jobst-Schwan","year":"2015","journal-title":"Kidney Blood Press. Res."},{"issue":"1","key":"10.1016\/j.bonr.2018.06.005_bb0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.abb.2011.11.003","article-title":"25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D","volume":"523","author":"Jones","year":"2012","journal-title":"Arch. Biochem. Biophys."},{"issue":"7","key":"10.1016\/j.bonr.2018.06.005_bb0090","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1210\/jc.2013-4388","article-title":"Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D by LC-MS\/MS involving derivatization with DMEQ-TAD","volume":"99","author":"Kaufmann","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.bonr.2018.06.005_bb0095","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/jbmr.3135","article-title":"Improved screening test for idiopathic infantile hypercalcemia confirms residual levels of serum 24,25-(OH)2 D3 in affected patients","volume":"32","author":"Kaufmann","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bonr.2018.06.005_bb0100","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/MPA.0000000000000577","article-title":"Hypercalcemic pancreatitis triggered by pregnancy with a CYP24A1 mutation","volume":"45","author":"Kwong","year":"2016","journal-title":"Pancreas"},{"issue":"6779","key":"10.1016\/j.bonr.2018.06.005_bb0105","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0140-6736(53)90187-1","article-title":"Idiopathic hypercalcaemia in infants","volume":"265","author":"Lightwood","year":"1953","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bonr.2018.06.005_bb0110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1042\/bj2620173","article-title":"Target cell metabolism of 1,25-dihydroxyvitamin D3 to calcitroic acid. Evidence for a pathway in kidney and bone involving 24-oxidation","volume":"262","author":"Makin","year":"1989","journal-title":"Biochem. J."},{"issue":"8","key":"10.1016\/j.bonr.2018.06.005_bb0115","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s004670050678","article-title":"Familial occurrence of idiopathic infantile hypercalcemia","volume":"13","author":"McTaggart","year":"1999","journal-title":"Pediatr. Nephrol."},{"issue":"2","key":"10.1016\/j.bonr.2018.06.005_bb0120","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/ckj\/sft008","article-title":"Medullary nephrocalcinosis in an adult patient with idiopathic infantile hypercalcaemia and a novel CYP24A1 mutation","volume":"6","author":"Meusburger","year":"2013","journal-title":"Clin. Kidney J."},{"issue":"4","key":"10.1016\/j.bonr.2018.06.005_bb0125","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1440-1754.1996.tb02569.x","article-title":"Prednisolone and cellulose phosphate treatment in idiopathic infantile hypercalcaemia with nephrocalcinosis","volume":"32","author":"Mizusawa","year":"1996","journal-title":"J. Paediatr. Child Health"},{"issue":"10","key":"10.1016\/j.bonr.2018.06.005_bb0130","doi-asserted-by":"crossref","first-page":"E1343","DOI":"10.1210\/jc.2014-4387","article-title":"CYP24A1 mutations in a cohort of hypercalcemic patients: evidence for a recessive trait","volume":"100","author":"Molin","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6929","key":"10.1016\/j.bonr.2018.06.005_bb0135","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0140-6736(56)91518-5","article-title":"Metabolic studies on two infants with idiopathic hypercalcaemia","volume":"270","author":"Morgan","year":"1956","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.bonr.2018.06.005_bb0140","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2215\/CJN.05360512","article-title":"1,25-(OH)2D-24 hydroxylase (CYP24A1) deficiency as a cause of nephrolithiasis","volume":"8","author":"Nesterova","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.bonr.2018.06.005_bb0145","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jpeds.2010.02.025","article-title":"Infantile hypercalcemia and hypercalciuria: new insights into a vitamin D-dependent mechanism and response to ketoconazole treatment","volume":"157","author":"Nguyen","year":"2010","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.bonr.2018.06.005_bb0150","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1365-2265.2008.03495.x","article-title":"Hyperparathyroidism during pregnancy and the effect of rising calcium on pregnancy loss: a call for earlier intervention","volume":"71","author":"Norman","year":"2009","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"10.1016\/j.bonr.2018.06.005_bb0155","first-page":"781","article-title":"Molecular definition of the chromosome 7 deletion in Williams syndrome and parent-of-origin effects on growth","volume":"59","author":"Perez Jurado","year":"1996","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.bonr.2018.06.005_bb0160","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s13353-017-0397-2","article-title":"Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH cases","volume":"58","author":"Pronicka","year":"2017","journal-title":"J. Appl. Genet."},{"issue":"10","key":"10.1016\/j.bonr.2018.06.005_bb0165","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/ccr3.646","article-title":"Hypercalcemia in pregnancy - a multifaceted challenge: case reports and literature review","volume":"4","author":"Rey","year":"2016","journal-title":"Clin. Case Rep."},{"issue":"6","key":"10.1016\/j.bonr.2018.06.005_bb0170","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s004670050654","article-title":"Hypercalcemia of the newborn: etiology, evaluation, and management","volume":"13","author":"Rodd","year":"1999","journal-title":"Pediatr. Nephrol."},{"issue":"5","key":"10.1016\/j.bonr.2018.06.005_bb0175","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1172\/JCI98680","article-title":"CYP3A4 mutation causes vitamin D-dependent rickets type 3","volume":"128","author":"Roizen","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bonr.2018.06.005_bb5000","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0022-3476(05)81738-X","article-title":"Normal values for random urinary calcium to creatinine ratios in infancy","volume":"123","author":"Sargent","year":"1993","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.bonr.2018.06.005_bb0180","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.eururo.2015.03.056","article-title":"Re: loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis","volume":"68","author":"Sayer","year":"2015","journal-title":"Eur. Urol."},{"issue":"4","key":"10.1016\/j.bonr.2018.06.005_bb0185","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/ckj\/sfv028","article-title":"Successful treatment of hypercalcaemia associated with a CYP24A1 mutation with fluconazole","volume":"8","author":"Sayers","year":"2015","journal-title":"Clin. Kidney J."},{"issue":"5","key":"10.1016\/j.bonr.2018.06.005_bb0190","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJMoa1103864","article-title":"Mutations in CYP24A1 and idiopathic infantile hypercalcemia","volume":"365","author":"Schlingmann","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bonr.2018.06.005_bb0195","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1681\/ASN.2014101025","article-title":"Autosomal-recessive mutations in SLC34A1 encoding sodium-phosphate cotransporter 2A cause idiopathic infantile hypercalcemia","volume":"27","author":"Schlingmann","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.bonr.2018.06.005_bb0200","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1210\/jc.2015-1973","article-title":"Maternal hypercalcemia due to failure of 1,25-Dihydroxyvitamin-D3 catabolism in a patient with CYP24A1 mutations","volume":"100","author":"Shah","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bonr.2018.06.005_bb0205","first-page":"160","article-title":"Intravenous pamidronate in the treatment of severe idiopathic infantile hypercalcemia","volume":"7","author":"Skalova","year":"2013","journal-title":"Iran. J. Kidney Dis."},{"issue":"3","key":"10.1016\/j.bonr.2018.06.005_bb0210","doi-asserted-by":"crossref","first-page":"E423","DOI":"10.1210\/jc.2011-1935","article-title":"Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy","volume":"97","author":"Tebben","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.bonr.2018.06.005_bb0215","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.4158\/EP13479.CR","article-title":"A case of \"late-onset\" idiopathic infantile hypercalcemia secondary to mutations in the CYP24A1 gene","volume":"20","author":"Wolf","year":"2014","journal-title":"Endocr. Pract."},{"issue":"10","key":"10.1016\/j.bonr.2018.06.005_bb0220","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/jbmr.2859","article-title":"A young woman with recurrent gestational hypercalcemia and acute pancreatitis due to CYP24A1 deficiency","volume":"31","author":"Woods","year":"2016","journal-title":"J. Bone Miner. Res."}],"updated-by":[{"DOI":"10.1016\/j.bonr.2021.101085","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000}}],"container-title":["Bone Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235218721830038X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235218721830038X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T19:52:35Z","timestamp":1606161155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235218721830038X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":45,"alternative-id":["S235218721830038X"],"URL":"https:\/\/doi.org\/10.1016\/j.bonr.2018.06.005","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.bonr.2021.101085","asserted-by":"object"}]},"ISSN":["2352-1872"],"issn-type":[{"value":"2352-1872","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Juvenile onset IIH and CYP24A1 mutations","name":"articletitle","label":"Article Title"},{"value":"Bone Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bonr.2018.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}